SMTL ID : 4hct.1

Crystal structure of ITK in complex with compound 52

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.48 Å

Oligo State

monomer

Ligands

1 x 18R: 3-{1-[(3R)-1-acryloylpiperidin-3-yl]-4-amino-1H-pyrazolo[3,4-d]pyrimidin-3-yl}-N-(3-tert-butylphenyl)benzamide(Non-covalent)

18R.1: 24 residues within 4Å: Chain A: I.18, G.19, S.20, Q.22, F.23, V.26, A.38, K.40, I.42, M.47, V.68, L.82, F.84, E.85, F.86, M.87, G.90, C.91, D.94, L.138, S.148, D.149, M.152, V.156 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:F.23, A:V.26, A:K.40, A:L.82, A:M.152 Hydrogen bonds: A:K.40, A:E.85, A:M.87, A:C.91, A:D.149 pi-Stacking: A:F.84 pi-Cation interactions: A:K.40

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Zapf, C.W. et al., Covalent inhibitors of interleukin-2 inducible T cell kinase (itk) with nanomolar potency in a whole-blood assay. J.Med.Chem. (2012)

Release Date

2012-11-14

Peptides

Tyrosine-protein kinase ITK/TSK: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase ITK/TSK

Related Entries With Identical Sequence